http://orcid.org/0000-0002-4738-5097
About the Authors
- R. Doug Wagner
-
* E-mail: doug.wagner@fda.hhs.gov
Affiliation Microbiology Division, National Center for Toxicological Research, Jefferson, Arkansas, United States of America
- Shemedia J. Johnson
-
Affiliation Microbiology Division, National Center for Toxicological Research, Jefferson, Arkansas, United States of America
- Zhixia Yan Danielsen
-
Affiliation Division of Clinical Pharmacology IV, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, White Oak, Maryland, United States of America
- Jin-Hee Lim
-
Affiliation NCTR/ORA Nanotechnology Core Facility Jefferson, Arkansas, United States of America
- Thilak Mudalige
-
Affiliation NCTR/ORA Nanotechnology Core Facility Jefferson, Arkansas, United States of America
- Sean Linder
-
Affiliation NCTR/ORA Nanotechnology Core Facility Jefferson, Arkansas, United States of America
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceptualization: RDW ZD SL. Data curation: RDW. Formal analysis: RDW JL TM. Funding acquisition: RDW. Investigation: RDW SJ JL TM SL. Methodology: RDW JL TM SL. Project administration: RDW SL. Resources: RDW SL. Supervision: RDW SL. Validation: RDW JL TM SL. Visualization: RDW. Writing – original draft: RDW. Writing – review & editing: RDW ZD.